NSECopy of Newspaper Publication1d ago · 3 Nov 2026, 02:51 pm

Copy of Newspaper Publication

Sun Pharma Advanced Research Company Limited · SPARC

✦ AI SummaryResults

Sun Pharma Advanced Research Company Limited has informed the Exchange about the publication of unaudited financial results for the quarter and half year ended September 30, 2026, in accordance with Regulation 33 read with Regulation 47(1) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Sun Pharma Advanced Research Company Limited has informed the Exchange about Copy of Newspaper Publication

Attachments (1)

📄

SPARC_03112026145110_InitimationNewspaper03112026.pdf

pdf

Download →
View document text
spare SPARC/Sec/SE/2026-27/47 November 03, 2026 National Stock Exchange of India Ltd., BSE Limited, Exchange Plaza, 5th Floor, Market Operations Dept. Plot No. C/1, G Block, P. J. Towers, Bandra Kurla Complex, Dalal Street, Bandra (East), Mumbai – 400 051. Mumbai - 400 001. Scrip Symbol: SPARC Scrip Code: 532872 Dear Sir/ Madam, Sub: Disclosure under Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) Pursuant to the provisions of Regulation 47 of the Listing Regulations, please find enclosed the copies of advertisement published on November 03, 2026, the extract of Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2026, in Financial Express (English Newspaper) all Editions and Financial Express (Gujarati Newspaper) Ahmedabad Edition. A copy of the newspaper clippings is attached herewith. These are also being made available on the website of the Company at https://sparc.life/ This is for your information and record. For Sun Pharma Advanced Research Company Ltd. Kajal Damania Company Secretary and Compliance Officer Encl: as above SunPharmaAdvancedResearchCompanyLtd. 17/B,MahalIndustrialEstate,OffMahakaliCavesRoad,Andheri(East),Mumbai400093,Maharashtra,India. Tel.:(91-22)66455645 |Fax.:(91-22)66455685|CIN:L73100GJ2006PLC047837|Website:www.sparc.life Registeredoffice:Plotno.5&6/1,SavliGIDCEstate,Manjusar391775,District:Vadodara,Gujarat,India. PSP Projects Limited CIN :L45201GJ2008PLC054868 POWAI LAKE RESIDENTIAL PRIVATE LIMITED Registered Office : PSP House, Opp. Celesta Courtyard, Opp. Lane of Vikram Nagar Colony, Iscon-Ambli Road, Ahmedabad - 380 058 Registered Office:One BKC, Level 18, Wing C, Plot No. C-66, G Block, Bandra Kurla Complex, Tel: +91 79 26936200/ +91 79 26936300, Email: grievance@pspprojects.com Bandra (East), Mumbai, Maharashtra, India, 400051 Website : www.pspprojects.com Website: h«Ds://www.residenceslakeview.com/, CIN: U68200MH2024FTC428724 UN-AUDITED FINANCIAL RESULTS (STANDALONE & CONSOLIDATED) STATEMENT OF STANDALONE UNAUDITED FINANCIAL FOR THE QUARTER AND HALF YEAR ENDED SEPTEMBER 30, 2026 RESULTS FOR THE QUARTER ENDED SEPTEMBER 30, 2026 The Board of Directors of the Company, at their Meeting held on Monday, November 02, 2026 The Standalone Unaudited Financial Results along with Limited Review Report approved the Un-Audited FinancialResults (Standalone & Consolidated) for the quarter and half for the quarter ended September 30, 2026 were reviewed and approved by the yearendedSeptember30, 2026. Board of Directors in their meeting held on November 02, 2026. Theresults,along withtheLimitedReviewReport,havebeenpostedontheCompany'swebsiteat The full format of the financialresults are available on thestock exchange website https://www.pspprojects.com/financial-performance/ and can be accessed by scanning the QR rji (www.bseindia.com) andontheCompany’s websiteat:https://residenceslakeview. code. com/wp-content/uploads/2026/11/Outcome-of-Board-Meeting-final-02112026.pdf The above intimation is in accordance withRegulation 33 read with Regulation 47(1) of the SEBI (Listing Obligation & and canbe accessed by scanning the QR code. DisclosureRequirements)Regulations,2015. For and on behalf of Board of Directors By Order of the Board, of PSP Projects Limited For Powai Lake Residential Private Limited Sd/- Sd/- Place : Ahmedabad Prahaladbhai S. Patel Anirudh Harlalka Date : November 02, 2026 Chairman & Managing Director, DIN: 00037633 Place: Mumbai Director Date : November 02, 2026 DIN: 02738144 Note: The above intimation is in accordance with Regulation 52 of the SEBI (Listing Obligation & Disclosure Requirements) Sun Pharma Advanced Research Company Limited Regulations,2015. spare Regd.Office:Plot No. 586/1,SavliGIDC Estate, Manjusar 391775,District:Vadodara, Gujarat,India CorporateOffice: 17-B, MahalIndustrial Estate,Mahakali CavesRoad,Andheri (E),Mumbai 400093. GUJARAT STATE FERTILIZERS & CHEMICALS LIMITED Tel: (91-22) 6645 5685 CIN:L73100GJ2006PLC047837 Website:https://sparc.life/ Email:secretarial@sparcmail.com Regd. Office:PO: Fertilizernagar-391750, Dist: Vadodara, Gujarat, India Unaudited Financial Results for the Quarter and Half Year ended September 30, 2026 CIN No. L99999GJ1962PLC001121 Tel:(0265) 2242451/651/751 Email:ho@gsfcltd.com Web: www.gsfclimited.com The Unaudited Financial Results of Sun Pharma Advanced Research Scan theQuick Response Company Limited ("SPARC") for the quarter and half year ended (QR) code to access the Extract of Standalone & Consolidated Unaudited Financial September 30, 2026 ("Q2 FY 27 Results") have been filed with the Stock Q2 FY 27 Result. Results for the quarter ended 30,n September, 2026 (?Incrores) Exchanges as per Regulation 33 of the SEBI (Listing Obligations and Standalone C:onsolidated DisclosureRequirements) Regulations, 2015. Sr. Quarter Quarter Half year Quarter Quarter Half year Particulars Q2 FY 27 Results areavailable on Company's website, https://sparc.life/, No. ended ended ended ended ended enaed 130-Sep-25|30-Sep-26| 30-Sep-25|30-Sep-26I and also on the websites of the Stock Exchanges, i.e., www.bseindia.com 30-Sep-26 30-Sep-26 andwww.nseindia.com 1 Total income fromoperations 4,711.35 3,139.91 8.292.75 4,740.94 3,187.37 8,324.09 2 Net Profit / (Loss) for theperiod 231.12 423.54 438.43 249.25 428.49 454.39 For and onbehalf of the Board (before tax.exceptional items) DilipS.Shanghvi 3 Net Profit / (Loss) for theperiod before tax 231.12 423.54 438.43 249.25 428.49 454.39 Chairman (afterexceptional items) Mumbai,November02,2026 4 Net Profit/ (Loss) for theperiodaftertax 183.08 320.08 344.19 200.24 324.11 358.78 sax (afterexceptionalitems) SAI PARENTERAL'S LIMITED 5 Total ComprehensiveIncome for theperiod 206.40 (103.08) 989.87 223.56 (99.04) 1,004.46 (Comprising Profit/(Loss) for theperiod (aftertax) and Extract of Un Audited Financials Results for the Quarter and Half Year ended 30th September 2026 OtherComprehensive Income(after tax)] 1 (AmountinINRinMillions) 6 Equity ShareCapital 79.70 79.70 79.70 79.70 79.70 79.70 Standalone Consolidated *2 Quarter Quarter Half Year HaltYear Year Quarter Half Year Half Year Year 7 Earnings Per Share (ofRs.2/- each) Particulars ended ended ended Mud ended ended ended ended X ^thSept 3UiSmI 301hSepl MUSm SM8MI lutnSer MAtai (forcontinuinganddiscontinuedoperations) 2025 2026 2025 2026 2025 2026 2026 UtAudMd UnAulile: UnAalilPi toit« toilet ft™ toilet 1. Basic (inRs.): 4.60 8.04 8.64 5.02 8.13 9.00 1 TotalIncomeIromOperations 565.01 484.05 1,126.93 688.48 1.649.93 1,986.37 548.63 3,810.50 894.27 3.895.18 2. Diluted (inRs.): 4.60 8.04 8.64 5.02 8.13 9.00 2 Net Profit/ (Loss) fortheperiod(beforeTax,Exceptional 86.97 81.71 20527 93.63 187.69 98 89 91.54 196.79 111.59 119.28 and/or Extraordinary items') Notes: 3 Net Profit/ (Loss) fortheperiodbefore tax(after Exceptional and/or Extraordinary items') 86.97 81.71 205.27 93.63 187.69 98.89 91.54 196.79 111.59 119.28 1. TheaboveisanextractofthedetailedformatofQuarterlyFinancialResultsfiledwiththeStockExchangesunderRegulation33ofthe Net Profit/ (Loss) fortheperiodaftertax (afterExceptional SEBI(ListingandOtherDisclosureRequirements)Regulations,2015.Thefullformatof theQuarterlyFinancialResults areavailable 4 and/or Extraordinary items') 64 86 56.39 153.61 64.64 t67 76 105.10 63.50 184.33 77.64 142.59 on the Stock Exchange websites (http://www.nseindla.com and http://www.bseindia.com) and on Company’s website TotalComprehensiveIncomefortheperiod[Comprising 5 Profit/ (Loss) fortheperiod(aftertax) and other 64.86 56.39 153 61 65.14 167 76 105.10 63.50 184 33 77.64 142.59 (http://www.gsfclimitedcom) Comprehensiveincome (aftertax)] 2. ThestatutoryAuditorsoftheCompanyhaveconducteda'limitedreview'oftheresultsforthequarterendedon30’September,2026. 6 EquitySnare Capital 220.90 220.90 220.90 220.90 220.90 220.90 184.54 220.90 184.54 220.90 7 EarningsPerShare(of Rs.10 i- each) (for [Showing first 8,000 characters — download PDF for full document]